Travel medicine for HIV-infected persons;Reisemedizinische aspekte bei HIV-infizierten patienten

Therapeutische Umschau

Volumn 58, Issue 6, 2001, Pages 381-386

  Rossi, M ^b   Furrer, H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; ATOVAQUONE PLUS PROGUANIL; BCG VACCINE; DIDANOSINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DOXYCYCLINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INDINAVIR; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; LOPINAVIR; MEASLES VACCINE; MEFLOQUINE; NELFINAVIR; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; QUINIDINE; QUINOLONE DERIVATIVE; RABIES VACCINE; RITONAVIR; SAQUINAVIR; UNINDEXED DRUG; YELLOW FEVER VACCINE; ZIDOVUDINE;

CHEMOPROPHYLAXIS; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG CONTRAINDICATION; EPIDEMIC ENCEPHALITIS; FOOD CONTROL; HEPATITIS A; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION; LEISHMANIASIS; MALARIA; MEASLES; PATIENT COUNSELING; PRESCRIPTION; RABIES; REVIEW; TRAVEL; TUBERCULOSIS; VACCINATION; YELLOW FEVER;

EID: 0034869057     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.58.6.381     Document Type: Review

References (30)

1. Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occuring after intiation of potent antiretroviral therapy. JAMA 1999; 282: 2220-6.
2. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
3. EKAF. Subkommission Klinik (SKK) der Eidg. Kommission für AIDS-Fragen (EKAF): Empfehlungen zur anti-retroviralen HIV-Therapie 2001. BAG Bulletin 2000; 51: 994-1000.
4. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-54.
5. Ledergerber B, Egger M, Opravil M, et al. Clinical progression and virologie failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 1999; 353 (9156): 863-8.
6. Colven R, Harrington RD, Spach DH, Cohen CJ, Hooton TM. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection. Ann Intern Med 2000; 133: 430-4.
7. Kilby MJ, Goepfert PA, Miller AP, et al. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: a case report. Ann Intern Med 2000; 133: 435-8.
8. Fuller JD, Carven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis 1999; 28: 541-7.
9. Tayal SC, Sankar KN. Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. AIDS 1994; 8: 558-9.
10. Gebo KA, Moore RD, Keruly JC, E. CR. Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients. J Infect Dis 1996; 173: 857-62.
11. Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R. Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against salmonella typhi (Typhim-Vi). Vaccine 1999; 17 (23-24): 2941-5.
12. Smith E, Thybo S, Bennedsen J. Infection with mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand J Infect Dis 1992; 24 (1): 109-10.
13. Karp CL, Neva FA. Tropical infectious diseases in human immunodeficiency virus infected patients. Clin Infect Dis 1999; 28: 947-65.
14. Lake-Bakaar G, Quadros E, Beidas S, Elsakr M, Tom W, Wilson DE. Gastric secretory failure in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109: 502-4.
15. Sperber SJ, Schleupner CJ. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis 1987; 9: 925-34.
16. Fernandez Guerrero ML, Ramos JM, Nunez A, Cuenca M, de Gorgolas M. Focal infections due to non-typhi salmonellae in patients with AIDS: report of 10 cases and review. Clin Infect Dis 1997; 25: 690-7.
17. Mosimann M, Nguyen XM, Furrer H. Exzessive wässrige Diarrhöe und Leistungsverminderung durch eine Cyclospora cayetanensis-Infektion bei einem HIV-infizierten Tropenaufenthalter. Schweiz Med Wochenschr 1999; 129: 1158-61.
18. Lopez-Velez R, Turrientes MC, Garron C, et al. Microsporidiosis in travelers with diarrhea from the tropics. J Travel Med 1999; 6 (4): 223-7.
19. Tswana SA, Nystrom L, Moyo SR, Nzara M, Boone P. The relationship between malaria and hiv. Cent Afr J Med 1999; 45: 43-5.
20. French N, Gilks CF. Fresh from the fields: some controversies in tropical medicine and hygiene. HIV and malaria, do they interact? Trans R Soc Trop Med Hyg 2000; 94 (3): 233-7.
21. Lee BL, Tauber MG, Sadler B, Goldstein D, Chambers HF. Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine. Clin Pharmacol Ther 1996; 59 (1): 14-21.
22. von Moltke LL, Greenblatt DJ, Duan SX, Daily JP, Harmatz JS, Shader RI. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo. J Pharm Sci 1998; 87 (10): 1184-9.
23. Khaliq Y, Gallicano K, Cameron DW, Carignan G, Seguin I. Mefloquine decreases ritonavir exposure in healthy volunteers.; 7th Conference on Retrovirusm and Opportunistic Infections Jan 30-Feb 2 2000; San Francisco, CA.
24. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267: 1237-41.
25. Anonymous. Measles pneumonitis following measles-mumps-rubella vaccination with HIV-Infection, 1993. MMWR 1996; 45: 603-6.
26. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C infection. N Engl J Med 1998; 338 (5): 286-90.
27. Furrer H, Weber R, Chan P, Egger M. Increased risk of wasting among Swiss HIV-infected people travelling to tropical or subtropical countries.; 7th European Conference on Clinical Aspects and Treatment of HIV-Infection October 23-27 1999; Lisbon, Portugal.
28. Schluger NW. Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients. Clin Infect Dis 1999; 28: 130-5.
29. Shafer RW, Edlin BR. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 1996; 22: 683-704.
30. Oehler T, Büchel B, Hatz C, Furrer H. Beratung HIV-Infizierter vor Reisen in tropische oder subtropische Gebiete. Schweiz Med Wochenschr 2000; 130: 1041-50.